Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Drugs/Products That May Increase Cancer Risk
  5. Drugs

Drugs

  • Anemia (51)
  • Blood Products (5)
  • Breast Cancer (56)
  • Cancer (19)
  • Cervical Cancer (18)
  • Chemotherapy (5)
  • Chemotherapy-Induced Adverse Effects (35)
  • Colon Cancer (17)
  • Drugs/Products That May Increase Cancer Risk (113)
    • Drugs (85)
    • Natural Medicines/Supplements (11)
    • Other (17)
  • Gastrointestinal Cancers (32)
  • Hemophilia (4)
  • Hemorrhage (7)
  • Leukemia (1)
  • Lung Cancer (93)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (5)
  • Prostate Cancer (29)
  • Renal Cancer (1)
  • Resources (75)
  • Sickle Cell Disease (3)
  • Skin Cancer (22)
76 - 85 of 85 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: concerns about using Protopic (tacrolimus) and Elidel (pimecrolimus) for eczema in kids May 2010
Commentary: Stelara (Ustekinumab) for Psoriasis November 2009
Article: new injectable biologic for moderate to severe plaque psoriasis called Stelara (stel-AR-a) November 2009
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Article: whether Lantus increases cancer risk August 2009
Article: whether Lantus increases cancer risk July 2009
Article: whether Vytorin causes cancer October 2008
Commentary: Drug Therapy for Ulcerative Colitis March 2007
Guideline: Guidelines for the Management of Inflammatory Bowel Disease in Adults (2004) March 2007
Other: What Should I Do About My Hormone Therapy? April 2004
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved